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BACKGROUND: A specific haplotype (AGATA) in the estrogen receptor alpha (ER1) gene was recently described as
a new risk factor for cryptorchidism in the Japanese population. In this ethnic group, single-nucleotide polymor-
phism 12 (SNP12) was concluded to be the tag SNP for the AGATA haplotype. MATERIALS AND METHODS: A
large group of patients (total number = 335) and controls (total number = 567) of two Caucasian populations were
analysed for the AGATA haplotype and SNP12 to verify whether this genetic variant and its tag SNP were associated
with cryptorchidism or with severe spermatogenic failure. RESULTS: We confirm that SNP12 is the tag SNP for the
AGATA haplotype also in Caucasians. However, in contrast with the Japanese population we found a protective
effect for ESR1 SNP12 on cryptorchidism in the Italian population. No association between SNP12 and severe sper-
matogenic disturbances was observed. CONCLUSIONS: The observed associations (although with opposite effect)
with cryptorchidism encourage future studies on independent cases and controls from different ethnic and geo-
graphic origins. On the other hand, in contrast with other ESR1 polymorphisms, SNP12 polymorphism is not associ-
ated with severe male factor infertility in two independent European population.
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Introduction
The testicular dysgenesis syndrome (TDS) is a clinical entity
grouping four different traits: cryptorchidism, low sperm
counts, hypospadias and testicular cancer (Sharpe and Skakkebaek,
1993). According to a current hypothesis, an increasing
exposure to xenoestrogens during fetal or perinatal life may
account for the reported increased incidence of TDS observed
in the last 50 years (Sharpe and Skakkebaek, 1993; Toppari
et al., 1996; Sharpe, 2003). Although the identification of envi-
ronmental compounds with estrogenic activity which could
affect the development of the male urogenital tract has received
great interest (Toppari et al., 1996; Joffe, 2003; Lottrup et al.,
2006), studies aimed to define genetic factors modulating the
action of estrogenic exposure are relatively scarce.
The two genes encoding for estrogen receptors alpha (ESR1)
and beta (ESR2) are the most obvious candidates for such a
modulating effect. A study claiming the association of a spe-
cific haplotype within the genomic region of the human ESR1
gene with idiopathic cryptorchidism in the Japanese population
has been recently published (Yoshida et al., 2005). In addition,
four independent studies based on different populations have
found association of genetic variants within the ESR1 gene
with male infertility (Kukuvitis et al., 2002; Suzuki et al.,
2002; Galan et al., 2005) or sperm production (Guarducci
et al., 2006).
Yoshida et al. (2005) analysed a set of 15 single-nucleotide
polymorphisms (SNPs), SNP1–SNP15, along the genomic
region of the ESR1 gene. The authors identified a haplotype
block of 50 kb encompassing SNP10–SNP14 (rs926779,
rs3020364, rs6932902, rs3020371 and rs3020375, respec-
tively) in the 3′ end of the ESR1 gene. According to these
authors, the specific haplotype AGATA, resulting from the
allelic combination of the five SNPs in the haplotype block, is
ESR1 AGATA haplotype and human cryptorchidism
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associated with cryptorchidism in the Japanese population.
Yoshida et al. (2005) found a higher frequency of the AGATA
haplotype in cryptorchid children (34.0%) when compared to
control children (21.3%). In addition, homozygosity for the
AGATA haplotype only appeared in the cryptorchid group.
According to Yoshida et al. (2005), SNP12 (rs6932902) is
the tag SNP for the AGATA haplotype. This fact allows the
analysis of the whole AGATA haplotype by testing only the
SNP12 in the Japanese population.
It is well known that the best way to confirm the findings
from a genetic association study is to obtain the same results by
analysing other independent series of cases and controls
(Hirschhorn et al., 2002). According to this concept, here, we
present the analysis of the SNP12 polymorphism in a group of
cryptorchid males of Italian origin. In addition, given the rela-
tionship between cryptorchidism and low sperm counts in the
context of TDS, we also aimed our study at evaluating the rela-
tionship between SNP12 polymorphism and infertility. For this
purpose, we tested SNP12 in two independent groups of infer-
tile men and two groups of control individuals from Italian and
Spanish populations.
Our results indicate that SNP12 is the tag SNP for the
AGATA haplotype also in Caucasians. However, in contrast
with the Japanese study, SNP12 could act as a protective, and
not as a susceptibility, factor for cryptorchidism in the Italian
population. On the other hand, the SNP12 polymorphism
does not seem to be associated with male infertility in either
the Italian or the Spanish populations.
Materials and methods
Study populations
Yoshida et al. (2005) described the frequency of the AGATA haplo-
type in the Japanese population. To establish the frequency of this
haplotype in two independent European populations, we recruited two
control groups from Italy and Spain, respectively.
The Italian control group includes 168 men from Central Italy with
normal sperm parameters and no history of cryptorchidism. For the
AGATA haplotype, we analysed 109 men, whereas all the 168 men
were screened for SNP12. Of the 168 men, 109 fathered at least one
child spontaneously or had normal fertilization after IVF for pure
female (tubal) factor infertility, whereas the remaining 59 men were
students from the local university.
Semen samples were obtained from all the Italian control individu-
als participating in this study. To minimize the variability of semen
analysis results, the duration of ejaculation abstinence was between 3
and 5 days. Semen analyses were performed according to the World
Health Organization guidelines (World Health Organization, 1999) at
the Andrology Laboratory of the University Hospital of Careggi
(Florence). Sperm morphology assessment was scored by determining
the percentage of normal and abnormal forms after Diff-Quick
staining, with a reference value of normal morphology of >30%
according to the third edition of the WHO manual (World Health
Organization, 1992).
The Spanish control group is constituted of 399 unrelated healthy
males from the Spanish general population. No semen samples were
available for these controls.
To test the effect of the AGATA haplotype on cryptorchidism in the
Italian population, we recruited a group of 118 cryptorchid males of
Italian origin (Central Italy); among them, 71 had a history of monolateral
cryptorchidism, whereas the remaining 47 men had bilateral cryp-
torchidism. Patients underwent karyotype analysis and screening for
the T22P mutation in the LGR8 gene and Y chromosome microdele-
tions. All the 118 patients satisfied the following criteria: (i) lack
of hypospadia or other genital abnormalities, (ii) normal 46,XY
karyotype and (iii) no Y deletions and no T222P mutation in the
LGR8 gene.
Given the relationship between cryptorchidism and male infertility,
we also examined the AGATA haplotype in two independent groups
of infertile men. One infertile group is constituted by 100 infertile
patients from Central Italy seeking complete andrological workup for
couple infertility. Semen samples from the Italian infertile men were
also obtained and analysed in the same way as for the Italian
controls. The other group comprises 117 infertile men from the Spanish
population.
Both the Italian and the Spanish patients underwent comprehensive
andrological examination including medical history, semen analysis,
scrotal ultrasound, hormone analysis, karyotype and Y chromosome
microdeletion screening according to Simoni et al. (2004). All
patients fulfil the following inclusion criteria: (i) azoospermia or
severe oligozoospermic (sperm counts <5 × 106 spz/ml) and (ii)
absence of any known cause of infertility such as cryptorchidism, var-
icocele (bilateral of grade 2 or mono/bilateral grade 3), obstructive
azoospermia, recurrent infections, iatrogen infertility, hypogonado-
trophic hypogonadism, karyotype anomalies and Y chromosome
microdeletions.
The referral centres are Andrology Unit and the Unit of Physiopa-
thology of Reproduction of the University Hospital Careggi (Florence,
Italy) for the Italian individuals and the Unit of Reproduction, Centro
Gutenberg (Malaga, Spain), the Centro Avanzado de Fertilidad (CAF)
(Cadiz, Spain) and the Centro de Reproduccion Asistida (CREA)
(Valencia, Spain) for the Spanish individuals.
Written informed consent was obtained from all the patients and
controls included in this study. The institutional review boards of
referral centres and Neocodex have approved this protocol. DNA
banking and genetic tests included in this study have complied with
the international regulations regarding the collection, treatment, storage
and use of genetic data (International Bioethics Committee, UNESCO
SHS-503/2001/CIB-8/3).
Molecular analysis
Germline DNA was extracted from peripheral blood in all the partici-
pants in this study with the exception of the Italian controls for whom,
depending on sample availability, the genomic DNA was isolated
either from the peripheral blood or from the frozen semen.
To genotype the five polymorphisms constituting the AGATA hap-
lotype in the two Caucasian control groups, we performed PCR proto-
cols in a final volume of 20 μl containing 20 ng of genomic DNA,
1.25 mM MgCl2, 62.5 μM deoxynucleotides triphosphates, 50 pmol
of each amplification primer and 2 IU Taq DNA polymerase (Roche
Diagnostics, Basel, Switzerland). PCRs were carried out in a PTC-
100® Peltier Thermal Cycler (MJ Research, Waltham, MA, USA).
We designed Pyrosequencing™ (Biotage AB, Uppsala, Sweden) gen-
otyping protocols in accordance with the manufacturer’s instructions.
Amplification and sequencing primers along with annealing tempera-
tures are summarized in Table I.
To test the accuracy of our genotyping protocols, we carried out
genotyping quality controls. All the markers included in this study
were checked by bidirectional sequencing in a CEQ 8000 automatic
sequencer (Beckman Coulter, Inc., Fullerton, CA, USA) using the
amplification primers in at least five random samples to verify the
genotypes obtained throughout Pyrosequencing™ technology (Biotage
AB) (data not shown). In addition, genomic DNA from 10% of all
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samples included in this study was newly extracted and genotyped. A
minimum of 99% of genotype coincidence was demanded for all five
markers.
Because the SNP12 is the tag SNP for the AGATA haplotype in the
Italian and the Spanish populations, the Italian cryptorchid and infertile
men and the Spanish infertile men were genotyped only for SNP12. The
genotyping of the SNP12 in the Italian cryptorchid group was performed
by direct bidirectional sequencing by using an automated sequencer
(ABI PRISM 310, Applied Biosystem, Foster City, CA, USA).
To test the accuracy and the reliability of both genotyping proto-
cols, we genotyped 24% of the Italian control individuals for SNP12
by using both protocols. A 100% match in genotyping results was
obtained for these individuals.
Statistical analyses
For statistical analysis of genotype distribution, test for deviation of
Hardy–Weinberg equilibrium (HWE) or two-point association stud-
ies, we employed tests adapted from Sasieni (1997). Odds ratio (OR)
estimates were computed from 2 by 2 tables. These calculations were
performed on the online resource facility at the Institute for Human
Genetics, Munich, Germany (http://ihg.gsf.de).
Semen parameter analyses were carried out using the Statistical Pack-
age for the Social Sciences Software (SPSS, Evanston, IL, USA). Owing
to non-parametric distribution of the seminal parameters, group compar-
isons were performed by Mann–Whitney U-test for unpaired data.
Haplotype construction and haplotypic frequencies were deter-
mined by using the Haploview software version 3.2 developed by The
International HapMap Project available at http://www.hapmap.org.
To include all the five SNPs in the haplotype analyses, we used the
‘Solid spine of LD’ for haplotypic block definition.
A P-value <0.05 was considered statistically significant in each
analysis.
Results
AGATA haplotype in the Italian and the Spanish control 
populations
To analyse the frequency of the AGATA haplotype, described by
Yoshida et al. (2005), in two independent European populations,
we genotyped the five SNPs that constitute this haplotype
(SNP10–SNP14) in two control groups from Italy and Spain.
The five SNPs are all intronic (intron 5 and intron 6), and their
NCBI accession number is the following: SNP10 rs926779,
SNP11 rs3020364, SNP12 rs6932902, SNP13 rs3020371 and
SNP14 rs3020375.
SNP10–SNP13 did not deviate from HWE law in either of
the two control groups analysed. However, we detected a devi-
ation of the HWE law for SNP14 in both control groups (data
not shown). Therefore, we decided to remove the SNP14 poly-
morphism from the haplotype analyses.
The haplotypes derived from the combination of the ESR1
gene polymorphisms in the Japanese and the two European
populations are indicated in Table II. As expected, the fre-
quency of the different haplotypes in the Italian and the Spanish
control groups was very similar.
However, the haplotype analyses revealed some differences
between the Japanese and the two European control groups.
Although the same four major haplotypes account for >92% of
the haplotype diversity in each control group, the frequencies
of these haplotypes are different between the Japanese and the
two European control groups. For example, the AGATA hap-
lotype is the second in frequency in the Japanese control group
and the third for the Italian and the Spanish groups.
In addition, it is worthy to note that Yoshida et al. (2005) did
not find any Japanese control individual being homozygous
for the AGATA haplotype, whereas one Italian and two
Spanish control individuals were found to be homozygotes for
this haplotype.
As in the Japanese control group, SNP12 is the tag SNP for
the AGATA haplotype in the two European control groups.
Therefore, we further focused our attention to this specific pol-
ymorphism, and we screened an additional 59 normospermic
subjects for this SNP. The allele frequency for SNP12 in the
Italian and the Spanish control populations is 13.4 and 9.3%,
respectively. The difference between these allelic frequencies
is statistically significant [P = 0.04, OR = 1.51, 95% confi-
dence interval (95% CI) = 1.02–2.25]. Therefore, we compared
patient and control groups within the same population to avoid
population stratification problems in our analyses.
SNP12 and cryptorchidism
We compared the allelic frequency and the genotype distribu-
tions of the SNP12 between the Italian cryptorchid group and
the Italian control group. None of these two groups deviate from
the HWE law for SNP12 (Table III). Interestingly, we observed a
Table I. Amplification and sequencing primers for the genotyping of the five 
single-nucleotide polymorphisms (SNPs) constituting the AGATA haplotype
B, biotin.
aAccession number of each polymorphism to dbSNP at 
http://www.ncbi.nlm.nih.gov.




SNP10 rs926779 B-gcattgaccagattcttcagtc 60
acgtgcgtagttagcaaacatc
tgctagtcgttagtaaaaac
SNP11 rs3020364 B-tcatttgggagactcttattgtcc 64
ctacaaaacagaatcaacgtcctg
gctggcctagatctca
SNP12 rs6932902 B-ggatatatacccagtagtggg 60
taaaagggtcttgggcatgga
gggagtcaccgttaag
SNP13 rs3020371 ttccactcacgtgcattgtgc 59
catccactgtgtggatcatac-B
tgaacctgtgccttctt
SNP14 rs3020375 B-taattctcaggagcgtgtgg 60
gtctctgcagcactcaatac
gcacagttccaagcat
Table II. Haplotype frequencies in three different populations
aHaplotypic frequencies for the Japanese control group described by Yoshida 
et al. (2005).
Haplotype Frequency in the 
Japanese populationa
(n = 47) (%)
Frequency in the 
Italian population
(n = 109) (%)
Frequency in the 
Spanish population
(n = 399) (%)
GAGCC 52.1 66.0 71.8
AGATA 21.3 8.5 8.7
GGGTA 9.6 4.4 4.6
AGGTA 9.6 14.0 12.2
ESR1 AGATA haplotype and human cryptorchidism
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statistically significant difference for SNP12 allelic frequency
between both groups. The A allele of the SNP12 polymorphism
presents a frequency of 13.4 and 7.2% in the Italian control
group and the cryptorchid group, respectively (Table III). Thus,
the A allele of SNP12 is possibly associated with a protective
factor for cryptorchidism in the Italian population (OR = 0.50)
(Table III). No statistically significant differences were detected
when the allelic frequency of SNP12 was compared between
monolateral and bilateral cryptorchid men (data not shown).
SNP12 and male infertility
To analyse the effect of SNP12 on male infertility, we com-
pared the allelic frequencies and genotype distribution of
SNP12 in the Italian and the Spanish infertile groups with their
population-matched controls. None of the analysed groups
deviated from HWE law for SNP12 (Table IV). We did not
observe any statistically significant difference between the
groups analysed (Table IV).
We also analysed the effect of SNP12 on three principal
sperm parameters (sperm concentration, motility and
morphology) in the Italian infertile group and the Italian
control group.
Because we detected only one homozygote individual for
SNP12 A allele in the Italian population, we compared the
sperm parameters between GG and GA plus AA individuals in
the two groups.
We did not observe any statistically significant association
of SNP12 genotype frequencies with any of the sperm parame-
ters analysed in either group (Table V).
Discussion
A specific haplotype (AGATA) located within the 3′ end of the
human ESR1 gene has been previously reported as a genetic
susceptibility factor for cryptorchidism in the Japanese popula-
tion (Yoshida et al., 2005). The SNP12 polymorphism of the
ESR1 gene has been reported as the key marker representing
the AGATA haplotype, and thus, the screening for this SNP
alone allows the detection of the proposed risk factor. In this
study, we have analysed the effect of the AGATA haplotype
Table III. Single-nucleotide polymorphism 12 (SNP12) statistical analyses in cryptorchidic and control groups from the Italian populations
95% CI, 95% confidence interval.
aTest for deviation from Hardy–Weinberg equilibrium (HWE) law (Exact test) in controls/cases.
bAllele frequency difference test (Pearson’s goodness-of-fit chi square).
cAllele positivity test (GG versus GA + AA).
Phenotype GG [n (%)] GA [n (%)] AA [n (%)] Minor allele 
frequency (%)
Statistical analyses, P value 
[odds ratio (95% CI)]
Italian cryptorchidic men 
(n = 118)
101 (85.59) 17 (14.41) 0 (0) 7.20 0.31/1.00a
Italian control men 
(n = 168)
124 (73.81) 43 (25.60) 1 (0.60) 13.39 0.02 [0.50 (0.28–0.90)]b
0.02 [0.47 (0.26–0.88)]c
Table IV. Single-nucleotide polymorphism 12 (SNP12) statistical analyses in male infertility in the Italian and the Spanish populations
95% CI, 95% confidence interval.
aTest for deviation from Hardy–Weinberg equilibrium (HWE) law (Exact test) in controls/cases.
bAllele frequency difference test (Pearson’s goodness-of-fit Chi square).
cAllele positivity test (GG versus GA + AA).
Group GG [n (%)] GA [n (%)] AA [n (%)] Minor allele 
frequency (%)
Statistical analyses, P value 
[odds ratio (95% CI)]
Italian infertile men (n = 100) 80 (80) 20 (20) 0 (0) 10 0.319/0.59a
Italian control men (n = 168) 124 (73.81) 43 (25.60) 1 (0.60) 13.39 0.24 [0.72 (0.41–1.26)]b
0.25 [0.71 (0.39–1.28)]c
Spanish infertile men (n = 117) 90 (76.92) 27 (23.01) 0 (0) 11.54 0.56/0.36a
Spanish control individuals (n = 399) 327 (81.95) 70 (17.54) 2 (0.50) 9.27 0.31 [1.28 (0.80–2.04)]b
0.22 [1.36 (0.83–2.25)]c
Table V. Analysis of the single-nucleotide polymorphism 12 (SNP12) on sperm parameters in the Italian control group and the Italian infertile group
SNP12 genotype Italian controls Italian infertile men
GG GA + AA P value 
(Mann–Whitney 
U-test)
GG GA + AA P value 
(Mann–Whitney 
U-test)
Sperm count [median (interquartile range)] 68.50 (54) 68 (61) 0.72 0.50 (2) 0.55 (3) 0.55
Motability [median (interquartile range)] 57 (17) 61 (20) 0.38 16 (22) 18 (7) 0.87
Morphology [median (interquartile range)] 38 (13) 38.50 (9) 0.88 12 (13) 8 (13) 0.24
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and, in particular, the SNP12 (rs6932902) polymorphism on
cryptorchidism and on severe spermatogenic disturbances in
two European populations.
We confirmed through the haplotype analyses that SNP12
polymorphism is the tag SNP for AGATA haplotype also in
the Italian and the Spanish general populations.
As far as the effect of SNP12 on cryptorchidism is con-
cerned, our results are in contrast with those from the Japanese
population. Although the SNP12 A allele is overrepresented in
the Japanese cryptorchid group when compared with its
population-matched controls (Yoshida et al., 2005), we
observed the opposite situation in the Italian population.
Therefore, the same allele of the SNP12 polymorphism acts as
a susceptibility factor in the Japanese population (OR = 1.92, P =
0.037) (Yoshida et al., 2005) and surprisingly as a protective
factor for cryptorchidism in the Italian population (OR = 0.50,
P = 0.02). It is also worth noting that in the Japanese study,
homozygote individuals for the A allele of SNP12 were identi-
fied only in the cryptorchid group (10 of 63) (Yoshida et al.,
2005). On the contrary, we have found only one AA homozy-
gote individual in the control group (1 of 168).
The observed differences could be due to the different
genetic backgrounds of the Japanese and our European popula-
tions. In fact, the SNP12 polymorphism presents allelic fre-
quencies of 21.3 and 13.4% in the Japanese (Yoshida et al.,
2005) and the Italian control populations, respectively. An
example for remarkable ethnic differences has recently been
described for other polymorphisms such as the DAZLA gene
exon 2, which was reported as a risk factor for male infertility
in the Chinese population but was completely absent in Euro-
pean populations (Becherini et al., 2004; Tschanter et al.,
2004).
Furthermore, a different genetic relationship (linkage dise-
quilibrium) between SNP12 and a putative cryptorchidism sus-
ceptibility factor could account for the different effects of
SNP12 in the two populations.
However, it is worthy to note that the number of cases (n = 63)
and the size of the control group (n = 47) in the paper by
Yoshida et al. (2005) are probably insufficient when dealing
with genetic association studies in multifactorial traits
(Ioannidis et al., 2001; Guarducci et al., 2006). In addition,
considering the HWE law and taking into account the
frequency of the AGATA haplotype in the Japanese control
group (21.3%), Yoshida et al. should have detected two Japanese
control individuals homozygous for this haplotype. Thus, it is
probable that a larger Japanese control group would include
some AGATA homozygous individuals.
Because common aetiological factors may lead to both cryp-
torchidism and spermatogenic disturbances, we investigated
whether the tag SNP for the AGATA haplotype (SNP12) may
also influence sperm production. Although the physiological
role of estrogens in spermatogenesis is not clearly defined, we
recently found an association between low sperm count and a
polymorphism (TA)n in the promoter region of the ESR1 gene
(Guarducci et al., 2006). In addition, three independent studies
found an association of ESR1 polymorphisms with male infer-
tility (Kukuvitis et al., 2002; Suzuki et al., 2002; Galan et al.,
2005).
To provide the most reliable information about the relation-
ship between SNP12 and infertility, we performed SNP12
analysis in two independent series of infertile men with severe
spermatogenic failure and controls from the Italian and the
Spanish populations. We found a lack of association between
the SNP12 and severe male factor infertility in both popula-
tions. Furthermore, we have not observed any effect of this
polymorphism on the three principal sperm parameters (con-
centration, motility and morphology) in either the Italian infer-
tile or the control groups. The analysis of the previously
reported ESR1 (TA)n polymorphism and SNP12 failed to
detect linkage disequilibrium between the two markers (data
not shown). This data further suggest that SNP12 is unlikely to
have a role in spermatogenesis.
In conclusion, we found the suggestion of a protective effect
for ESR1 SNP12 on cryptorchidism in the Italian population.
Whether the discrepancy between our study and the Japanese
study is related to sample size or to genuine ethnic or environ-
mental differences remains unresolved. However, the observed
associations (although with opposite effect) with cryp-
torchidism encourage future studies on independent cases and
controls from different ethnic and geographic origins. On the
other hand, in contrast to other ESR1 polymorphisms, the
SNP12 polymorphism does not appear to be associated with
severe male factor infertility or with sperm production in
European populations.
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